| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quince Therapeutics, Inc. (QNCX) has 7 insiders with recent SEC Form 4 filings, including 4 buys and 14 sells. QNCX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 739.9K | $699.2K | - | |
| COO | 45.2K | $42.7K | - | |
| ? | 39.2K | $37.0K | - | |
| ? | 29.4K | $27.8K | - | |
| ? | 21.8K | $20.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | Thye Dirk52 | Chief Executive Officer | Buy | 80,000 | $1.24 | $99,200.00 | +28.5% | -21.3% | -43.4% | |
| Aug 8, 2023 | Hannah Brendan63 | Chief Business Officer | Buy | 71,762 | $1.22 | $87,549.64 | +55.3% | -21.3% | -43.4% | |
| Aug 8, 2023 | McLoughlin Margaret58 | Director | Buy | 8,000 | $1.23 | $9,840.00 | New | -21.3% | -43.4% | |
| Mar 6, 2023 | Monohon Ted | Chief Accounting Officer &VP | Sell | 1,871 | $0.98 | $1,833.58 | -6.4% | +46.4% | +21.3% | |
| Jun 6, 2022 | McDowell Caryn Gordon | Chief Legal &Adm. Officer | Sell | 10,800 | $2.86 | $30,922.56 | -8.1% | -43.5% | -47.9% | |
| Nov 12, 2021 | Dominy Stephen S. | Chief Scientific Officer | Buy | 763 | $14.40 | $10,987.20 | - | -61.6% | -94.2% | |
| Oct 8, 2021 | McLoughlin Margaret58 | Director | Sale+OE | 1,000 | $88.93 | $88,930.00 | -100% | -86.4% | -98.7% | |
| Oct 5, 2021 | Lowe Christopher P.77 | COO &Chief Financial Officer | Sale+OE | 4,963 | $98.50 | $488,855.50 | -7.6% | -86.2% | -98.7% | |
| Aug 16, 2021 | McLoughlin Margaret58 | Director | Sale+OE | 6,000 | $95.44 | $572,643.52 | -52.8% | -84.4% | -97.7% | |
| Aug 16, 2021 | Lowe Christopher P.77 | COO &Chief Financial Officer | Sale+OE | 22,000 | $95.31 | $2,096,778.94 | -11.2% | -84.4% | -97.7% |